Jennifer Jarrett, Director, President and CEO at Damora Therapeutics, bought DMRA on Sep 25, 2026
Data as of Oct 16
▲ BUY$253K12,500 shares at $20.23Jennifer Jarrett Director, President and CEODMRA Damora Therapeutics, Inc.
- Traded
- Sep 25, 2026
- Disclosed
- Sep 28, 2026
- Filed
- 3 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
DMRA since disclosure
−11.1%
Similar stocks (XLV) since disclosure
+3.2%
XLV — its sector index fund
Change in closing price from Sep 28, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.